688192.SS
688192.SS
CNE1000055W8
DIZAL PHARMACEUTICAL CO LTD
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 801.135.558 359.900.621
122.6%
Cost of Revenue 34.228.877 9.316.309
267.4%
Gross Profit 766.906.681 350.584.312
118.8%
1.527.234.229 1.283.424.873
19.0%
Operating Income -760.327.548 -932.840.561
18.5%
Pretax Income -767.126.713 -939.651.337
18.4%
Net Income Common Stockholders -764.049.493 -845.956.286
9.7%
-- --
--
-- --
--
ende